June 22, 2022
Article
New phase 3 data show a microencapsulated form of the topical antiseptic and vitamin D derivative is beneficial and tolerable over 12 weeks.
June 21, 2022
Video
Savanna Perry, PA-C, discussed the challenge of standing out over influencers and estheticians regarding clinical dermatology insight, and the unique offerings of different platforms.
New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.
June 20, 2022
Results from a cross-sectional survey suggest consistent patient preferences for treatment outcomes and means of administration.
Savanna Perry, PA-C, founder of The PA Platform, discusses the strategies and goals that go into building an online audience as a healthcare professional.
New phase 3 extension data show the topical PDE-4 inhibitor provided skin clearance to a significant rate of patients with psoriasis.
Associations Between Glaucoma and Cognitive Function Not Substantial
Karolinne Rocha, MD: Advancements in Cataract, Refractive Surgery
Causal Relationship Not Established Between COVID-19 Infection, Retinal Vein Occlusion
